Ticker League

Alnylam Pharmaceuticals (ALNY) Cash Flow Waterfall

Trace Alnylam Pharmaceuticals's operating cash flow down to free cash flow, then see where FCF goes — capex, buybacks, dividends, and debt repayment.

TTM

Operating CF

$713M

Capex

-$71.6M

Free Cash Flow

$641M

FCF Margin

+90.0%

Cash flow waterfall for Alnylam Pharmaceuticals (ALNY) — TTM through Q1 2026

Free cash flow: $641M

Note: Other Investing is large — driven mainly by purchases or sales of investments.

Cash flow breakdown for Alnylam Pharmaceuticals (ALNY) — TTM through Q1 2026

  • Operating Cash Flow$713M
  • Capital Expenditure-$71.6M
  • Free Cash Flow$641M
  • Other Investing$369M
  • Net Debt Change-$553M
  • Other Financing$219M
  • Forex Effect$13.8M
  • Net Cash Increase$690M
Want to see what drove the FCF change?Free Cash Flow Bridge

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation